Synthetic blood to be made avaible

by badboy 9 Replies latest jw friends

  • badboy
    badboy

    presumbly jws will be using this product

  • blondie
    blondie

    If you mean like Hemopure, or other hemoglobin-based products, jws have already used them without being censured by the WTS. Despite that the products are made out of expired STORED blood.

  • slimboyfat
    slimboyfat

    I saw that news item too badboy.

    Over time I think it will eliminate the need for blood. The Watchtower leadership will no doubt be very relieved because it is a way out of an awkward situation.

    http://news.bbc.co.uk/1/hi/health/7958582.stm

  • neverendingjourney
    neverendingjourney
  • badboy
    badboy

    BTTT

  • parakeet
    parakeet

    badboy, do you know the source of this information? If you do, please let us know. Also who is conducting the clinical trials and where. Unless, as Blondie pointed out, it's something already on the market.

  • Elsewhere
    Elsewhere

    JWs will not be using this. It is blood, made from stem cells.

    Blood is blood. JWs won't use it.

  • blondie
    blondie

    Stem cell products is something else.......but hemoglobin based products are now being used, and made from stored blood, and by jws.

    Scott E. Smith 1 , Amir Toor 1 , Tulio Rodriguez 1 and Patrick Stiff 1

    (1) Cardinal Bernardin Cancer Center, Lyola University Medical Center, 2160 South First Avenue, 60153 Maywood, IL

    Received: 8 June 2006 Accepted: 13 June 2006

    Abstract A 55-yr-old woman with a history of B-cell lymphoma of the nasopharynx diagnosed in March 1999 eventually underwent submyeloablative allogeneic stem cell transplantation from a sibling donor in December 2002 after conventional treatment options were exhausted. The treatment approach was some-what altered by the fact that the patient was a practicing Jehovah's Witness and refused blood-blood product transfusion. The course of her treatment was unremarkable until around day 100 posttransplant when she developed graft failure, leading to severe anemia. Blood transfusions were refused. Donor cells were re-infused. During this treatment period, the patient's hemoglobin dropped to a low of 2.7 g/dL, with the patient experiencing severe fatigue, dyspnea on exertion, headaches, and blurred vision. Polymerized human hemoglobin (pyridoxylated) (Poly-Heme ™ , Northfield Laboratories Inc., Evanston, IL) was given under an emergency, compassionate use protocol and successfully bridged the patient's hemoglobin and relieved symptoms during her marrow recovery period. http://www.springerlink.com/content/l07p000q7p78420n/ ARTICLE LINKS:
    Fulltext | PDF (380 K) Critical Care Medicine : Volume 30(8) August 2002 pp 1893-1895

    Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: New treatment strategies*

    [Case Reports]

    Gannon, Christopher J. MD; Napolitano, Lena M. MD, FCCM

    From the Department of Surgery, University of Maryland School of Medicine and VA Maryland Health Care System, Baltimore, MD.

    Abstract

    Objective: Management of severe anemia in a critically ill Jehovah's Witness is challenging. In the past, conservative therapy was the only option available to the practitioner. Recently, new interventional treatment strategies have become available, including human and bovine hemoglobin substitutes and high-dose recombinant human erythropoietin.

    Design: Case report.

    Setting: Intensive care unit in a quaternary care center.

    Patient: A patient with severe, life-threatening anemia caused by gastrointestinal hemorrhage who refused all blood products on religious grounds.

    Intervention: Bovine hemoglobin substitute and high-dose recombinant human erythropoietin.

    Case Study: A 50-yr-old Jehovah's Witness presented with massive upper gastrointestinal hemorrhage; initial hemoglobin was 3.5 g/dL. Endoscopy revealed a prepyloric ulcer, and hemorrhage control was achieved by epinephrine injections into the peri-ulcer mucosa. Despite control of hemorrhage, the patient became hemodynamically unstable. A total of 7 units of a bovine hemoglobin-based oxygen carrying compound (HBOC-201) was administered to enhance the patient's oxygen delivery. High-dose recombinant human erythropoietin was administered daily (500 units/kg). Hemoglobin levels were initially maintained and then slowly increased to a maximum of 7.6 g/dL on day 24 of therapy.

    Conclusion: This case demonstrates that the concurrent administration of hemoglobin-based oxygen carriers and recombinant human erythropoietin in severe, life-threatening anemia (hemoglobin, 3.5 g/dL) was associated with patient survival and a significant increase in hemoglobin to 7.6 g/dL, without the administration of allogeneic blood. Hemoglobin-based oxygen carriers can adequately serve as initial therapy to maintain tissue oxygen delivery while awaiting the maximal effect of recombinant erythropoietin on bone marrow red blood cell production. High-dose recombinant human erythropoietin offers these patients the best chance for normalization of hematocrit and survival in the long term.

    © 2002 Lippincott Williams & Wilkins, Inc.

  • rebel8
    rebel8

    There has been synthetic hemophilia clotting factor on the market for years. (Wish it worked for me.)

    dubs shake their finger at me, telling me I should be taking that instead of the medication I use, calling me a liar when I point out it doesn't work for my particular condition (lots of proof exists, including the anecdotal evidence of it not working on me!). They also act in the typical holier-than-thou, smarter-than-you manner, pretending I didn't know about it because there is a Satanic conspiracy among doctors to get people to keep drinking blood.

    Old-time paranoid folklore is alive and well in the jw religion. (AMA = American Medical Association. This pic is from wt publications.)

  • parakeet
    parakeet

    Thanks for the info, blondie.

Share this

Google+
Pinterest
Reddit